NXS 7.94% 34.0¢ next science limited

Hi,I understand that pple are upset with the revenue forecast....

  1. 428 Posts.
    lightbulb Created with Sketch. 67
    Hi,

    I understand that pple are upset with the revenue forecast. However, it could be due to so many issues, for example,

    (a) customers might have delayed their orders in June to the next quarter;
    (b) revenue definition: revenues are recognized when they are realized or realizable, and are earned (usually when goods are transferred or services rendered), no matter when cash is received. Customers might have placed orders but due to COVID restrictions between Mexico (location of manufacture of NXS products) to the customer's home country (delays in transport), revenue is recognized only when title of goods is received by customers. Therefore, customers might have placed orders in June but revenue can't be recognized in June if title of goods is only received by customers in July.
    (c) NXS has just launched Xperience, it is unlikely that they are able to forecast revenue in current quarter.

    In the meantime, those 3 clinical trials are important to convince the surgeons.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.025(7.94%)
Mkt cap ! $99.17M
Open High Low Value Volume
33.5¢ 34.0¢ 32.0¢ $67.10K 201.9K

Buyers (Bids)

No. Vol. Price($)
2 58000 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 54296 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
32.5¢
  Change
0.025 ( 1.56 %)
Open High Low Volume
33.5¢ 33.5¢ 32.5¢ 42908
Last updated 15.59pm 26/04/2024 ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.